The notably higher AUC values of CD5L and TGFβ1- in comparison with APRI- suggest that while APRI can serve as a valuable screening tool for liver fibrosis, there may be limitations in its specificity compared to more sensitive markers. The gene discussed is TGFB1; the disease is Hepatic fibrosis.